What we do

To achieve our Mission, the Foundation funds some of the most brilliant minds in neuroscience. Having recognized that no one laboratory has the compass to tackle the complex challenges of peripheral neuropathy, the Foundation organized a collaborative approach that will allow researchers to achieve a high level of trust, openness and collaborative interaction marked by dynamic, interactive and intellectual and scientific relationships between them. Collaborative efforts will foster the exchange of new information and cutting edge technologies with academic and industry researchers alike. We hope to increase the movement of new treatments into the clinic. Ultimately, the more that is known about the function and dysfunction of the nervous system, the more individuals can be helped to have a better future.

he Clinical Research Training Scholarship (CRTS) award aims to recognize the importance of good clinical research and to encourage early career investigators in clinical studies

Since 2023, we have partnered with the American Brain Foundation (ABF) and the American Academy of Neurology (AAN), to award $150,000 research grants dispersed over the course of two years. The grant is being administered through ABF’s Next Generation Research Grants program. For most recipients, this grant is their first major, independent research award. It provides an opportunity to gain experience managing a grant-funded research award while in a mentored environment. Since the start of the program in 1993, approximately $33M has been provided to more than 300 researchers. Over 80% of recipients have gone on to secure additional research funding from the NIH, NIA, and other sources.

The Foundation for Peripheral Neuropathy is honored to be able to partner with some of the greatest scientists to help facilitate their clinical research trials on peripheral neuropathy, often able to serve as a platform to connect researchers and industry leaders with a population of peripheral neuropathy patients for clinical trials. Under-enrollment in trials is one of the greatest challenges clinical researchers face as it slows research progress and deters potential funders from investing in research. We all pay the price in terms of higher costs and longer time horizons to get to therapeutic breakthroughs. Across all diseases, 85 percent of clinical trials finish late due to difficulties enrolling participants and nearly one-third of trials fail to recruit a single subject and cannot ever begin.

To achieve our Mission, the Foundation funds some of the most brilliant minds in neuroscience. No one laboratory has the capacity to tackle the complex challenges of peripheral neuropathy alone. The Foundation organized a collaborative approach that will allow researchers to achieve a high level of trust, openness and collaborative interactions marked by dynamic, interactive and intellectual and scientific relationships between them.